Rabeprazole is a proton pump inhibitor of the substituted benzimidazole class used to treat conditions such as gastroesophageal reflux disease, peptic ulcers, and hypersecretory disorders by irreversibly… Read more













![Chemical structure of 1-Nitroso-1H-benzo[d]imidazol-2-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-Nitroso-1H-benzodimidazol-2-ol.png&w=3840&q=75)
![Chemical structure of 2-(((1H-Benzo[d]imidazol-2-yl)thio)methyl)-4-(3-methoxypropoxy)-3-methylpyridine 1-oxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F924663-40-1-2-1H-Benzodimidazol-2-ylthiomethyl-4-3-methoxypropoxy-3-methylpyridine-1-oxide.png&w=3840&q=75)
![Chemical structure of 2-(((4-(3-Chloropropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1613482-73-7-2-4-3-Chloropropoxy-3-methylpyridin-2-ylmethylsulfinyl-1H-benzodimidazole.png&w=3840&q=75)
![Chemical structure of 2-(((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methyl)thio)-1-nitroso-1H-benzo[d]imidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-4-3-Methoxypropoxy-3-methylpyridin-2-ylmethylthio-1-nitroso-1H-benzodimidazole.png&w=3840&q=75)
![Chemical structure of 2-(((4-Methoxy-3-methylpyridin-2-yl)methyl)thio)-1-nitroso-1H-benzo[d]imidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-4-Methoxy-3-methylpyridin-2-ylmethylthio-1-nitroso-1H-benzodimidazole.png&w=3840&q=75)

![Chemical structure of 2-[(4-Chloro-3-methyl-2-pyridinyl)methylthio]-1H-benzimidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F103312-62-5-2-4-Chloro-3-methyl-2-pyridinylmethylthio-1H-benzimidazole.png&w=3840&q=75)


![Chemical structure of 3-((4-Methylbenzo[4,5]imidazo[1,2-b]pyrido[1,2-d][1,2,4]thiadiazin-3-yl)oxy)propanal](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3-4-Methylbenzo45imidazo12-bpyrido12-d124thiadiazin-3-yloxypropanal.png&w=3840&q=75)
![Chemical structure of 3-Methyl-1-(1-nitroso-1H-benzo[d]imidazol-2-yl)-4-oxo-1,4-dihydropyridine-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3-Methyl-1-1-nitroso-1H-benzodimidazol-2-yl-4-oxo-14-dihydropyridine-2-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of 4-((1H-Benzo[d]imidazol-2-yl)oxy)-3-methylpicolinic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1286104-27-5-4-1H-Benzodimidazol-2-yloxy-3-methylpicolinic-Acid.png&w=3840&q=75)





![Chemical structure of N-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl] Rabeprazole Sulfide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1114543-47-3-N-4-3-Methoxypropoxy-3-methyl-2-pyridinylmethyl-Rabeprazole-Sulfide.png&w=3840&q=75)
















Rabeprazole is a proton pump inhibitor of the substituted benzimidazole class used to treat conditions such as gastroesophageal reflux disease, peptic ulcers, and hypersecretory disorders by irreversibly inhibiting the gastric H+/K+ ATPase enzyme. To support pharmaceutical development and regulatory compliance, a comprehensive range of reference standards, including pharmacopeial and non-pharmacopeial impurities, degradation products, and metabolites, is essential for accurate impurity profiling and analytical method validation. These high-quality reference materials, alongside stable isotope labelled compounds, serve as critical benchmarks in mass spectrometry and quality control laboratories. By facilitating the precise identification and quantification of impurities and metabolic derivatives, these standards enable researchers to confirm the potency, stability, and safety of the parent drug during routine development and long-term stability testing. Ensuring reliable data across these analytical processes is fundamental to meeting rigorous quality standards in the pharmaceutical industry.